Millennium Pharmaceuticals Inc - DC District of Columbia, Washington 20001

Millennium Pharmaceuticals Inc entered the industry of Industry Specialist Consultants in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 541611, which describes it as a Industry Specialist Consultants. For further clarification, the SIC classifies this business under the code 8742 and described it as a Industry Specialist Consultants. The business provides service to the B2B market.

To acquire more information, please contact Tom Fussaro by calling (202) 289-2018 during business hours. You can also write to the business’ Branch at 750 9th St Nw # 575, Washington, District of Columbia DC 20001. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Millennium Pharmaceuticals Inc
Representative: Tom Fussaro
Place of Business: 750 9th St Nw # 575, Washington, DC 20001
Contact Number: (202) 289-2018
Type of Service: Industry Specialist Consultants
SIC Number: 8742
NAICS Number: 541611
Locality: Branch
Market Type: B2B (Business to Business)
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Millennium Pharmaceuticals Inc is a company operating from District of Columbia, District of Columbia providing professional Industry Specialist Consultants and relevant B2B variables. It was founded in 0 and registered with the SIC code 8742 as Industry Specialist Consultants, and with the NAICS code 541611 as Industry Specialist Consultants.

With a current employee count of 1 to 4, Millennium Pharmaceuticals Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Tom Fussaro at (202) 289-2018 for related queries, or to locate its Branch using the coordinates 38.899403,-77.024121.

The Branch can also be found at the street address 750 9th St Nw # 575 in Washington, District of Columbia 20001 and can be engaged online through the company website at , the company Twitter , and Facebook page .